查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1937085

全球神經科學市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global Neuroscience Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 144 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計神經科學市場將從 2025 年的 567.3 億美元成長到 2034 年的 967.4 億美元，2026 年至 2034 年的複合年成長率為 6.11%。

由於阿茲海默症、帕金森氏症和多發性硬化症等神經系統疾病的日益增多，神經科學市場預計將迎來顯著成長。隨著全球人口老化和慢性病負擔的加重，神經科學領域對有效診斷和治療方案的需求激增。神經影像技術、生物標記發現和藥物研發的進步正在改變神經系統疾病的治療格局，使醫療服務提供者能夠提供更具針對性和個人化的治療。隨著研究人員和臨床醫生致力於改善神經系統疾病患者的治療效果和生活品質，這一趨勢預計將推動市場格局的發展。

調查方法和技術的創新正在塑造神經科學市場的未來前景。人工智慧和機器學習的融合提高了分析複雜神經學數據的能力，從而改善了患者分層和治療效果。此外，神經刺激技術和神經調控療法的進步為神經系統疾病的治療開闢了新途徑，為患者提供了非侵入性的症狀緩解方案。隨著研究不斷揭示神經系統疾病的潛在機制，針對疾病進展特定路徑的新型治療方法有望陸續推向市場。

此外，隨著製藥公司和學術機構認知到神經科學領域創新解決方案的緊迫性，加強研發投入將對神經科學市場產生正面影響。神經科、研究人員和行業相關人員之間的合作對於推進臨床試驗和確保新療法的應用至關重要。在這種不斷變化的環境下，監管機構有望簡化創新治療方法的核准流程，使神經系統疾病患者能夠更快地獲得有效的治療方案。將神經科學融入綜合醫療保健策略將變得日益重要，這將進一步凸顯早期診斷、病​​患教育和持續支持在神經系統疾病管理中的重要性。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 繪製滲透率和成長前景圖
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制
    • 市場機遇
    • 市場問題
  • 波特五力分析
  • PESTLE分析

4. 全球神經科學市場（按組成部分分類）

  • 市場分析、洞察與預測
  • 裝置
  • 消耗品
  • 軟體和服務

5. 全球神經科學市場（依技術分類）

  • 市場分析、洞察與預測
  • 腦部影像
  • 神經顯微鏡
  • 立體定位手術
  • 神經蛋白質體學分析
  • 神經元操控
  • 其他

6. 全球神經科學市場（依最終用戶分類）

  • 市場分析、洞察與預測
  • 醫院
  • 診斷檢查室
  • 研究和學術機構

7. 全球神經科學市場（按地區分類）

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商格局（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Carl Zeiss AG
    • Danaher Corporation
    • GE Healthcare
    • Siemens Healthcare Private Limited
    • Koninklijke Philips NV
    • Canon Inc
    • B. Braun SE
    • Medtronic
    • Stryker
    • Boston Scientific Corporation
    • Abbott
    • Terumo Corporation
簡介目錄
Product Code: VMR11215038

The Neuroscience Market size is expected to reach USD 96.74 Billion in 2034 from USD 56.73 Billion (2025) growing at a CAGR of 6.11% during 2026-2034.

The neuroscience market is poised for substantial growth, driven by the increasing prevalence of neurological disorders, such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. As the global population ages and the burden of chronic diseases rises, the demand for effective diagnostic and therapeutic solutions in neuroscience is surging. Advances in neuroimaging, biomarker discovery, and drug development are transforming the landscape of neurological care, enabling healthcare providers to offer more targeted and personalized treatment options. This trend is expected to propel the market forward, as researchers and clinicians seek to improve patient outcomes and enhance the quality of life for individuals with neurological conditions.

Innovations in research methodologies and technologies are shaping the future of the neuroscience market. The integration of artificial intelligence and machine learning is enhancing the ability to analyze complex neurological data, leading to improved patient stratification and treatment outcomes. Additionally, advancements in neurostimulation techniques and neuromodulation therapies are providing new avenues for managing neurological disorders, offering patients non-invasive options for symptom relief. As research continues to uncover the underlying mechanisms of neurological diseases, the market is likely to witness the introduction of novel therapies that target specific pathways involved in disease progression.

Moreover, the neuroscience market will benefit from increased investment in research and development, as pharmaceutical companies and academic institutions recognize the urgent need for innovative solutions in this field. Collaborative efforts between neurologists, researchers, and industry stakeholders will be essential in advancing clinical trials and ensuring the successful implementation of new therapies. As the landscape evolves, regulatory bodies are expected to streamline approval processes for innovative treatments, facilitating faster access to effective solutions for patients with neurological disorders. The focus will increasingly shift towards integrating neuroscience into comprehensive healthcare strategies, emphasizing the importance of early diagnosis, patient education, and ongoing support in managing neurological conditions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Component

  • Instruments
  • Consumables
  • Software & Services

By Technology

  • Brain Imaging
  • Neuro-Microscopy
  • Stereotaxic Surgeries
  • Neuro-Proteomic Analysis
  • Neuro-Cellular Manipulation
  • Others

By End-User

  • Hospitals
  • Diagnostic Laboratories
  • Research And Academic Institute

COMPANIES PROFILED

  • Carl Zeiss AG, Danaher Corporation, GE Healthcare, Siemens Healthcare Private Limited, Koninklijke Philips NV, Canon Inc, B Braun SE, Medtronic, Stryker, Boston Scientific Corporation, Abbott, Terumo Corporation

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEUROSCIENCE MARKET: BY COMPONENT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Component
  • 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Software & Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEUROSCIENCE MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Technology
  • 5.2. Brain Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Neuro-Microscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Stereotaxic Surgeries Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Neuro-Proteomic Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Neuro-Cellular Manipulation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEUROSCIENCE MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Research And Academic Institute Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NEUROSCIENCE MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Component
    • 7.2.2 By Technology
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Component
    • 7.3.2 By Technology
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Component
    • 7.4.2 By Technology
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Component
    • 7.5.2 By Technology
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Component
    • 7.6.2 By Technology
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL NEUROSCIENCE INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Carl Zeiss AG
    • 9.2.2 Danaher Corporation
    • 9.2.3 GE Healthcare
    • 9.2.4 Siemens Healthcare Private Limited
    • 9.2.5 Koninklijke Philips N.V
    • 9.2.6 Canon Inc
    • 9.2.7 B. Braun SE
    • 9.2.8 Medtronic
    • 9.2.9 Stryker
    • 9.2.10 Boston Scientific Corporation
    • 9.2.11 Abbott
    • 9.2.12 Terumo Corporation